Mechanisms and pathology of monocrotaline pulmonary toxicity.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsBioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animal modelsProtein targets of monocrotaline pyrrole in pulmonary artery endothelial cells.Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertensionDown-regulation of TRPM8 in pulmonary arteries of pulmonary hypertensive rats.Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.Pyrrolizidine alkaloids--genotoxicity, metabolism enzymes, metabolic activation, and mechanisms.Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in miceSelective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.Enhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research.Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in miceEvidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.Reactive oxygen species in pulmonary vascular remodeling.Experimental and transgenic models of pulmonary hypertension.Molecular pathogenesis and current pathology of pulmonary hypertension.Hypertensive rat lungs retain hallmarks of vascular disease upon decellularization but support the growth of mesenchymal stem cells.Nestin-expressing vascular wall cells drive development of pulmonary hypertension.Rosuvastatin intensifies the beneficial effects of rho-kinase inhibitor in reversal of monocrotaline-induced pulmonary hypertension.Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension.Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats.Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension.Role of cardiac inflammation in right ventricular failure.Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.Low doses of monocrotaline in rats cause diminished bone marrow cellularity and compromised nitric oxide production by peritoneal macrophages.Smad signaling in the rat model of monocrotaline pulmonary hypertension.Opinion of the Panel on contaminants in the food chain [CONTAM] related to pyrrolizidine alkaloids as undesirable substances in animal feedImmune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension.Mice with focal pulmonary fibrosis caused by monocrotaline are insensitive to urethane induction of lung tumorigenesis.A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
P2860
Q26766294-0C3C040D-C08E-474E-BB1E-98DD56CF22D9Q28768721-B4F01201-C742-401A-81DA-939E196184A4Q30883318-DE3686A9-17A1-4156-B04F-ADF923390048Q33160867-B40DD60A-13C2-4F86-8B59-1692F35D7FF9Q33393513-7DE78797-B5F0-4BC6-9F77-F0E1888C0EC2Q33634204-50771B76-0771-4A46-A026-28E823247F6AQ33668314-919CCB15-EA39-478B-89C7-2F7B4ACF0A85Q34270071-4320FA5A-C6A7-4101-A1A4-5C091DB95339Q34312030-36B82E5A-F0ED-46A6-ADC0-CB4731DA902CQ34940129-B66210E5-9698-4621-93A6-A18E62FCC529Q35677930-BC59FA01-5C78-4991-A840-51C0A70D64C0Q35832692-18EDB38A-D9EB-4220-8460-1A62CACB3FE2Q35895691-24CE86E5-663A-4A2C-BCCE-29AF6FE32739Q36267289-189C71C9-FDB1-4852-8DE1-64ECB0C11E27Q36539476-E66987D5-6D9C-4EA3-AF9D-8419038D0CDCQ37100760-80FBF4E7-38EF-4AF6-B2B5-E2D24B2A9664Q37211166-7C0CD098-0E64-452E-AEB5-99CF4932249DQ37532988-1BC102DD-80D0-4D35-BF3E-BEFFD2C3520EQ38112056-F4AE66A5-FBDB-495F-BE67-DB9DBC2527C2Q38676413-A605C091-525B-48AA-8256-49E5E8893D2DQ39278713-6E4981C9-8374-4B60-9425-B20324F2E8B8Q40176131-C31FE0FC-06E5-426E-BC33-6DE506053166Q42100559-07B149E4-60CA-4CEB-9D9E-1C76893F6E5AQ43227366-1DC2F50F-0FD8-4B0F-87BA-4C36DC7970A6Q43270607-D5EAAAC6-A17D-4A0F-8CDF-611ACAE234AAQ43280246-CF4A6DB3-2B1D-4E05-B3E9-0B1119133DAAQ44575160-EE8855BE-BFEE-47D2-B918-1D5FEE8759E8Q45023018-4EB4FE7C-F395-4AFF-9DB7-59609A9B18E0Q45068688-60378BC7-B96E-4250-A4FC-E04DD83A2291Q45280686-43EA1219-4266-4164-9A0E-535A67AC3597Q45961733-AFC6B0A5-32E0-4508-851F-C87B257A8718Q45973154-E4CD0082-5E37-423F-A921-D9BA49FB7ECFQ46158773-8A9C0409-7CCE-4FAB-BC1A-EF7F4D0E869DQ47144776-FDA7BC94-8FB6-4E0D-B441-9FC8F7662A5EQ49600503-3F629321-4698-4D66-94AF-5022A0505D21Q51144698-A55B0D73-6BE6-4E97-8B8E-7D653781F491Q51531670-53655E39-F7F1-43CF-96B7-82F0E309D8FBQ52654089-E2CD702A-41A0-4661-B970-80C12F463D2F
P2860
Mechanisms and pathology of monocrotaline pulmonary toxicity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@ast
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@en
type
label
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@ast
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@en
prefLabel
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@ast
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@en
P2093
P2860
P1476
Mechanisms and pathology of monocrotaline pulmonary toxicity.
@en
P2093
P2860
P304
P356
10.3109/10408449209146311
P407
P577
1992-01-01T00:00:00Z